Pharmaceutical giant Pfizer will raise the list prices of 41 medications early next year, the Wall Street Journal reports. The company said in a statement that those higher prices are "expected to be offset by higher rebates and discounts."
Why it matters: Pfizer is following through on comments from last month, when CEO Ian Read said the company would resume its "normal" practice of raising drug prices — indicating that the company's temporary pause in price increases, following criticism from President Trump, was mostly political posturing.
